- United States
- /
- Diversified Financial
- /
- NYSE:EVTC
Market Participants Recognise EVERTEC, Inc.'s (NYSE:EVTC) Earnings
EVERTEC, Inc.'s (NYSE:EVTC) price-to-earnings (or "P/E") ratio of 19x might make it look like a sell right now compared to the market in the United States, where around half of the companies have P/E ratios below 16x and even P/E's below 9x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the elevated P/E.
Our free stock report includes 2 warning signs investors should be aware of before investing in EVERTEC. Read for free now.With earnings growth that's superior to most other companies of late, EVERTEC has been doing relatively well. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.
View our latest analysis for EVERTEC
What Are Growth Metrics Telling Us About The High P/E?
The only time you'd be truly comfortable seeing a P/E as high as EVERTEC's is when the company's growth is on track to outshine the market.
Retrospectively, the last year delivered an exceptional 43% gain to the company's bottom line. However, this wasn't enough as the latest three year period has seen a very unpleasant 21% drop in EPS in aggregate. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.
Shifting to the future, estimates from the six analysts covering the company suggest earnings should grow by 18% per year over the next three years. That's shaping up to be materially higher than the 11% per year growth forecast for the broader market.
With this information, we can see why EVERTEC is trading at such a high P/E compared to the market. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.
The Key Takeaway
Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.
As we suspected, our examination of EVERTEC's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. Unless these conditions change, they will continue to provide strong support to the share price.
And what about other risks? Every company has them, and we've spotted 2 warning signs for EVERTEC (of which 1 is concerning!) you should know about.
It's important to make sure you look for a great company, not just the first idea you come across. So take a peek at this free list of interesting companies with strong recent earnings growth (and a low P/E).
Valuation is complex, but we're here to simplify it.
Discover if EVERTEC might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:EVTC
EVERTEC
Provides transaction processing and financial technology services in Latin America, Puerto Rico, and the Caribbean.
Undervalued with proven track record.
Similar Companies
Market Insights
Weekly Picks

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

EU#4 - Turning Heritage into the World’s Strongest Luxury Empire

The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story
Recently Updated Narratives

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Novo Nordisk - A Fundamental and Historical Valuation

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Popular Narratives

The "Sleeping Giant" Stumbles, Then Wakes Up
Undervalued Key Player in Magnets/Rare Earth

